Literature DB >> 22648552

Laryngeal cancer: quantitative and qualitative assessment of research output, 1945-2010.

Ronan W Glynn1, Aoife J Lowery, Cristian Scutaru, Tadhg O'Dwyer, Ivan Keogh.   

Abstract

OBJECTIVES/HYPOTHESIS: To provide an in-depth evaluation of research yield in laryngeal cancer from 1945 to 2010, using large-scale data analysis, employment of bibliometric indicators of production and quality, and density equalizing mapping. STUDY
DESIGN: Bibliometic analysis incorporating the Web of Science Database.
METHODS: The search strategy employed was as follows; "TS = ((Laryngeal Neoplasm$) OR (Larynx Neoplasm$) OR (Larynx Cancer$) OR (Laryngeal Cancer$))." Author and journal data and cooperation networks were computed following analysis of combinations of countries and institutions that registered cooperation during the study period. Mapping was performed as described by Groneberg-Kloft in 2004.
RESULTS: A total of 8,658 items relating to laryngeal cancer were published over the study period, accounting for 139,700 citations. The United States was the most prolific country, accounting for 28.83% (n = 2,496) of total output. Other prolific nations included Italy (n = 794) and Germany (n = 792). There were 973 items published as a consequence of international cooperation; this practice increased steadily over time and accounted for 15.58% (88 of 565) of output in 2010. There were 1,073 different journals publishing articles on laryngeal cancer, although the top 20 (1.8%) most prolific titles were together responsible for more than 43% of the total output; these were led by Laryngoscope (n = 368) and Head and Neck, Journal of the Scientific Specialties (n = 364). A total of 24,682 authors contributed to the literature on laryngeal cancer; the leading author by output was Alfio Ferlito (n = 120); Carlo La Vecchia recorded the highest h-index (h = 32).
CONCLUSIONS: This work represents the first attempt to provide quantitative and qualitative analysis of laryngeal cancer research output, whilst in tandem identifying the key bibliometric benchmarks to which those involved in the production of that output might aspire.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22648552     DOI: 10.1002/lary.23401

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Impact of lymph node ratio on the survival of patients with hypopharyngeal squamous cell carcinoma: a population-based analysis.

Authors:  Yu-Long Wang; Shou-Hao Feng; Ji Zhu; Guo-Pei Zhu; Duan-Shu Li; Yu Wang; Yong-Xue Zhu; Guo-Hua Sun; Qing-Hai Ji
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

2.  Type 2 Diabetes Research Yield, 1951-2012: Bibliometrics Analysis and Density-Equalizing Mapping.

Authors:  Fiona Geaney; Cristian Scutaru; Clare Kelly; Ronan W Glynn; Ivan J Perry
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

3.  Gendermetrics of cancer research: results from a global analysis on lung cancer.

Authors:  Michael H K Bendels; Dörthe Brüggmann; Norman Schöffel; David A Groneberg
Journal:  Oncotarget       Date:  2017-10-26

4.  Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study.

Authors:  Qintong Duan; Yufeng Li; Lijia Ou; Yajun Li; Ruolan Zeng; Yizi He; Tao Pan; Siwei Chen; Huan Chen; Hui Zang; Hui Zhou; Ling Xiao
Journal:  J Cancer       Date:  2022-03-14       Impact factor: 4.207

5.  Social sciences research in the Central European city of Wrocław: A density-equalizing mapping analysis.

Authors:  David A Groneberg
Journal:  PLoS One       Date:  2018-10-24       Impact factor: 3.240

6.  A world map of evidence-based medicine: Density equalizing mapping of the Cochrane database of systematic reviews.

Authors:  David A Groneberg; Stefan Rolle; Michael H K Bendels; Doris Klingelhöfer; Norman Schöffel; Jan Bauer; Dörthe Brüggmann
Journal:  PLoS One       Date:  2019-12-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.